Publicaciones en las que colabora con José Manuel Cózar Olmo (82)

2024

  1. Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family

    Cancer Communications

2023

  1. Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  2. Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study

    Quality of Life Research, Vol. 32, Núm. 4, pp. 977-988

2022

  1. Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer

    Science of the Total Environment, Vol. 843

  2. Patrones dietéticos y cáncer de próstata: estudio CAPLIFE

    Revista española de nutrición humana y dietética, Vol. 26, Núm. 3, pp. 14-15

  3. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

2021

  1. Biofabrication of a tubular model of human urothelial mucosa using human wharton jelly mesenchymal stromal cells

    Polymers, Vol. 13, Núm. 10

  2. Epididimitis tuberculosa

    Archivos espanoles de urologia, Vol. 74, Núm. 3, pp. 365-366

  3. The role of prostate-specific antigen in light of new scientific evidence: An update in 2020

    Actas Urologicas Espanolas, Vol. 45, Núm. 1, pp. 21-29

  4. Tumor escape phenotype in bladder cancer is associated with loss of HLA class I expression, T-cell exclusion and stromal changes

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2020

  1. Impact of oxidative stress SNPs and dietary antioxidant quality score on prostate cancer

    International Journal of Food Sciences and Nutrition, Vol. 71, Núm. 4, pp. 500-508

  2. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 139-147

2019

  1. A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer

    Annals of Surgical Oncology, Vol. 26, Núm. 8, pp. 2631-2639

  2. Adherence to Mediterranean diet and risk of prostate cancer

    Aging Male, Vol. 22, Núm. 2, pp. 102-108

  3. GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity

    Urologic Oncology: Seminars and Original Investigations, Vol. 37, Núm. 4, pp. 290.e9-290.e15

  4. The role of miRNAs as biomarkers in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 165-174

  5. Usefulness of 18F-fluorocoline PET/CT in prostate cancer patients with biochemical recurrence: Influence of PSA kinetics and hormone therapy

    Medicina Clinica, Vol. 153, Núm. 2, pp. 56-62

2018

  1. Alteración de la excreción urinaria de calcio en pacientes sometidos a deprivación androgénica por cáncer de próstata. Resultados preliminares de un estudio piloto

    Archivos Espanoles de Urologia, Vol. 71, Núm. 7, pp. 569-574

  2. Genetic markers a landscape in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 775, pp. 1-10

  3. Improving the genetic signature of prostate cancer, the somatic mutations

    Urologic Oncology: Seminars and Original Investigations, Vol. 36, Núm. 6, pp. 312.e17-312.e23